Searchable abstracts of presentations at key conferences in endocrinology

ea0026p376 | Thyroid (non cancer) | ECE2011

The use of lithium and perchlorate therapy in special cases of hyperthyroidism

Kun I Z , Szanto Zs , Bartok T , Pop Radu C C , Pascanu I

Objective: To study the efficacy of lithium and perchlorate in special cases of hyperthyroidism: thioamide-resistant or iodine-induced thyroxicosis/thyrotoxic pre-crisis, hematological adverse effects of methimazole, leukopenia of other causes.Material and methods: Twenty-seven hyperthyroid patients received lithium carbonate and/or potassium perchlorate, majority after methimazole-therapy (associated with folic acid in leukopenia). We followed the clini...

ea0019p228 | Pituitary | SFEBES2009

Severe acute psychosis precipitated by replacement dose hydrocortisone in newly diagnosed panhypopituitarism

Mada S , Palmer C C , Mhando Y , Rao P , Erukulapati R , Nag S

Introduction: Psychiatric disturbance is a recognised complication of glucocorticoid therapy. Patients on a daily dose of 40 mg of prednisolone or its equivalent are at risk of developing steroid psychosis. Psychotic reactions with replacement doses of glucocorticoid are uncommon. We describe a patient with newly diagnosed hypopituitarism who developed severe steroid induced psychosis with low dose hydrocortisone.Case report: A 72-year-old lady presented...

ea0086p166 | Adrenal and Cardiovascular | SFEBES2022

Review of multidisciplinary perioperative management of functioning and non-functioning adrenal lesions at The University Hospital Southampton NHSFT (UHS)

Bujanova Jana , Bray Diane , Richard W Lockyer C , C Hayes Matthew , Douglas James , Crabb Simon , Chance Thomas , Al-Mrayat Ma'en

Objective: We reviewed perioperative management of patients undergoing adrenal surgery at UHS between 1/12/2020 to 1/6/2022 (19-month period) since formalisation of its regional adrenal MDT.Results: 45 adrenalectomies were performed during this period with all cases being discussed at the adrenal MDT, of which 24 (53%) were referred from peripheral hospitals. Laparoscopic surgery was performed in 35/45 (78%) (median length of stay (LOS): 3d), open in 10/...

ea0026oc1.6 | Thyroid/Adrenal | ECE2011

Increased risk of infections in patients with Addison's disease

Smans L C C J , Souverein P C , Leufkens H G M , Hoepelman I M , Zelissen P M

Context: Previous studies have suggested that infections are an important cause of death in patients with Addison’s disease, but epidemiological studies on the frequency of infections in this population are scarce.Design and setting: We conducted a cohort study, using data from the Dutch PHARMO record linkage system, linking patients’ demographics and medical histories to the use of prescription drugs, diagnostic and therapeutic data from hospi...

ea0031oc2.4 | Steroids and thyroid | SFEBES2013

THRA or DIO2 mutations are not a common cause of high bone mass in humans

Gogakos A I , Bassett J H D , Gluer C C , Reid D M , Felsenberg D , Roux C , Eastell R , Williams G R

Mice with dominant-negative mutations of thyroid hormone receptor α1 (TRα1) are euthyroid but display growth retardation and delayed bone age as juveniles and increased bone mass during adulthood, indicating impaired skeletal thyroid hormone responsiveness. The first autosomal dominant mutations affecting TRα1 in humans were recently described in two unrelated children and one parent who were euthyroid apart from a low T4:T3 ratio. Consiste...

ea0026p234 | Pituitary | ECE2011

Does GH replacement therapy reduce mortality in adults with GH deficiency? Data from the Dutch National Registry of GH Treatment in adults

van Bunderen C C , van Nieuwpoort I C , Arwert L I , Heymans M W , Franken A A M , Koppeschaar H P F , van der Lely A J , Drent M L

Introduction: Adults with GH deficiency (GHD) have a decreased life expectancy due to cardiovascular diseases (CVD). Recombinant GH treatment has made replacement therapy an option in adults with GHD. Data on long-term efficacy and safety are limited and the implication for life expectancy remains to be established.Methods: The Dutch National Registry of GH Treatment in Adults was founded to gain more insight into long-term efficacy and safety of GH ther...

ea0026p251 | Pituitary | ECE2011

Lost to follow-up in acromegaly, results of ACROSPECT observational study

Delemer B D , Reines C R , Brue T B , Rudelli C C Cortet , Raingeard I R , Reznik Y R , Parot X P , Chabre O C

Lost to follow-up (LTFU) is a frequent problem in chronic diseases not evaluated yet in acromegaly despite the long-term need of medical treatment and complications survey in this disease.Objectives: Evaluation of the prevalence of LTFU patients in a multi-center cohort, characteristics of defaulters and description of their evolution after they have been searched and found.Méthods: Observational multicentric (25 centers study...